The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in the prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack1,2 OCEANIC-AF and OCEANIC-STROKE are expected to enroll up to 30,000 patients in over … [Read more…]
~30% relative risk reduction seen in symptomatic ischemic strokes in three milvexian arms compared to placebo; dose response not observed for primary study objective No fatal bleeding and no increase in symptomatic intracranial hemorrhage observed in patients treated with milvexian, even with all patients receiving 21 days of background dual antiplatelet therapy followed by single … [Read more…]
Pre-specified pooled analysis from Phase III trials demonstrated reduction in CV death by 14% and reduction in death from any cause by 10% in patients with heart failure irrespective of ejection fraction First heart failure medication to demonstrate mortality benefit across the full ejection fraction range Results being presented at the European Society of Cardiology … [Read more…]
Results presented at European Society of Cardiology Congress 2022, and published in New England Journal of Medicine Data extend the clinically meaningful benefits of FARXIGA in patients with heart failure regardless of ejection fraction Heart failure is a chronic, progressive disease impacting nearly 64 million people WILMINGTON, Del.–(BUSINESS WIRE)–Detailed results from the DELIVER Phase III … [Read more…]
Global Leader in Infection Prevention to Showcase Innovative Healthcare Products that Clean, Protect, and Test BOSTON & LONDON–(BUSINESS WIRE)–2San, a trusted global Tier 1 supplier of high-quality innovative healthcare products and solutions that Clean, Protect, and Test, will exhibit for the first time at the National Association of Chain Drug Stores (NACDS) Total Store Expo … [Read more…]
TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, announced today that, in relation to the executive changes announced on July 25, 2022, a grant of 965,000 stock options (“Options”) to certain officers of the Company at an exercise price of $0.30 … [Read more…]
Event brings together the leading innovators, influencers and executives to design what’s next for the senior living industry and aging community SAN FRANCISCO–(BUSINESS WIRE)–On August 29, 2022, SafelyYou, who empowers safer, more person-centered dementia care through its world-leading, real-time AI video technology and 24/7 remote clinical experts, will be hosting its inaugural Silicon Valley Senior … [Read more…]
NIAGARA, Ontario–(BUSINESS WIRE)–extractX Ltd. (“extractX” or the “Company”), today announced financial results for the Company and its subsidiary extractX Incorporated (“EXI”) as at and for the three and nine months ended June 30, 2022. All figures are in Canadian dollars unless otherwise noted. Q3 2022 Operational Highlights During the quarter the Company continued to work … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Voice Biometrics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Component, Type, Authentication Process, Deployment, Vertical, and Application” report has been added to ResearchAndMarkets.com’s offering. The global voice biometrics market share is expected to grow from US$ 1,319.23 million in 2021 to US$ 4,823.85 million by 2028; the voice biometrics … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Nutraceutical Ingredients Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Nutraceutical Ingredients Market is projected to reach USD 292.75 billion by 2027 from USD 178.16 billion in 2021, at a CAGR 8.62% during the forecast period. Market Statistics: The report provides market sizing and … [Read more…]
